logo
Dr. Becky: TIME100 Creators 2025

Dr. Becky: TIME100 Creators 2025

Yahoo09-07-2025
Credit - Melanie Dunea
During the COVID-19 pandemic, clinical psychologist Becky Kennedy emerged as a modern-day Dr. Spock for a new generation of anxious, overwhelmed parents. The 42-year-old mother of three is known for speaking directly to the camera—often on New York City streets after dropping off her children at school or a sports game—and sharing personal parenting anecdotes and practical advice with an audience of more than 3.4 million across Instagram and TikTok.
Kennedy's philosophy centers on the belief that every child, even one who's mid-tantrum, is 'good inside'—a phrase that's evolved into the title of her chart-topping podcast, best-selling book, and parenting platform, which offers paid workshops on everything from screentime to sibling rivalry. Rather than focusing on punishment, Kennedy equips parents with scripts and strategies to help their kids feel seen, heard, and understood. For millions of Millennials, Dr. Becky has become the go-to voice of reason in the chaos of child-rearing.
Data and insights powered by #paid
Write to Eliana Dockterman at eliana.dockterman@time.com.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Herz P1 Smart Ring: 24/7 Health Monitoring, Sleep, Stress & Heart Rate Tracking
Herz P1 Smart Ring: 24/7 Health Monitoring, Sleep, Stress & Heart Rate Tracking

Yahoo

time22 minutes ago

  • Yahoo

Herz P1 Smart Ring: 24/7 Health Monitoring, Sleep, Stress & Heart Rate Tracking

WuzuTech's Herz P1 Smart Ring: Revolutionizing Wellness with 24/7 Health Monitoring, Real-Time Insights, and Continuous Tracking New York City, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Herz P1 Smart Ring: 24/7 Health Monitoring, Sleep, Stress & Heart Rate Tracking IN THIS RELEASE, YOU'LL DISCOVER: Why demand for wearable health monitoring devices is accelerating in 2025 How the Herz P1 Smart Ring tracks heart rate, sleep patterns, stress levels, and activity metrics around the clock The design elements that make Herz P1 comfortable for all-day, all-night wear The role of real-time data insights in improving personal wellness decisions Market trends showing how smart rings are reshaping the future of health technology Which types of users benefit most from 24/7 wearable monitoring solutions Balanced perspectives on the strengths and limitations of smart ring technology Herz P1's mission to make advanced health tracking accessible and easy to use TL;DR SUMMARY The Herz P1 Smart Ring is a next-generation wearable designed to deliver 24/7 health monitoring, including heart rate tracking, sleep analysis, stress measurement, and activity tracking — all in a sleek, comfortable ring. As consumer interest in personalized wellness technology grows in 2025, the Herz P1 stands out for its blend of precision sensors, minimalist design, and real-time data feedback. This article explores why demand for smart rings is surging, how Herz P1 works, who it's designed for, and the broader trends shaping the wearable health market. With balanced insights into both the advantages and limitations of smart ring technology, readers will gain a clear understanding of how the Herz P1 Smart Ring fits into the future of health and wellness. SECTION 1 — WHY INTEREST IN 'SMART RINGS' IS SURGING IN 2025 The global wearable technology market is experiencing one of its most significant shifts yet in 2025 — and smart rings are at the center of this transformation. While smartwatches have long dominated the space, a growing number of consumers are seeking devices that deliver comprehensive health insights without the bulk or constant on-screen distractions. This demand has fueled a surge in interest for sleek, discreet wearables like the Herz P1 Smart Ring, which offers advanced tracking capabilities while maintaining a minimal footprint in daily life. Several market forces are driving this trend. First, the wellness industry has expanded its focus from fitness alone to overall health optimization, placing greater value on continuous, passive monitoring of vital signs. The rise of preventative health is reshaping how consumers view their overall health management. Today's wearables, including the Herz P1, play an integral part in this transformation, empowering individuals to track metrics like heart rate, sleep patterns, and stress levels in real time. Second, more individuals are prioritizing stress management, sleep quality, and heart health as key components of long-term well-being — areas where smart rings excel due to their constant skin contact and high sensor accuracy. According to recent studies, stress-related illnesses and sleep disorders are on the rise globally, further driving the demand for accessible solutions like the Herz P1 Smart Ring. Third, technological advancements have made it possible to pack precision sensors, Bluetooth connectivity, and long-lasting batteries into a compact, stylish form factor. As consumer awareness increases about the power of data-driven decisions, real-time data combined with long-term trend tracking helps users adjust their routines to achieve optimal health outcomes. The growing intersection of fashion, comfort, and technology positions smart rings not just as gadgets but as integral tools for everyday health management. With the Herz P1, users gain access to advanced health insights without sacrificing style or comfort. . SECTION 2 — HOW THE HERZ P1 SMART RING DELIVERS 24/7 HEALTH MONITORING The Herz P1 Smart Ring is engineered to provide continuous, around-the-clock health tracking without disrupting daily routines or sleep. Its design integrates advanced biometric sensors directly into a lightweight titanium alloy band, ensuring constant skin contact for optimal reading accuracy. Unlike bulkier devices, the ring format allows for consistent wear — even while sleeping, exercising, or performing everyday activities. At the core of its functionality is a multi-sensor system capable of capturing key wellness metrics in real time. This includes heart rate monitoring, sleep cycle analysis, stress level measurement, and activity tracking, all of which are transmitted to a companion app for easy review. The app's dashboard organizes data into intuitive charts and trends, making it simple for users to understand their health patterns and identify changes over time. The sleep tracking feature is particularly notable. By monitoring resting heart rate, micro-movements, and body temperature, it can map out light, deep, and REM sleep stages, offering actionable insights into how rest quality impacts overall wellness. Sleep is often overlooked in wellness regimens, but its importance in recovery, mood regulation, and cognitive function is clear. The Herz P1 helps individuals understand the direct impact their sleep has on their health, including how external factors like stress and exercise influence sleep patterns. The stress monitoring function also utilizes heart rate variability (HRV) to detect elevated tension levels, enabling users to take proactive steps toward relaxation and recovery. This level of monitoring, while valuable for anyone, can be especially beneficial for busy professionals or parents who face high daily stressors. Battery efficiency is another advantage — the Herz P1 Smart Ring is designed for extended wear between charges, ensuring uninterrupted monitoring for days at a time. Combined with its durable, water-resistant construction, the device supports a seamless integration into users' daily lives while maintaining accuracy and reliability in various environments. SECTION 3 — KEY FEATURES THAT MAKE THE HERZ P1 STAND OUT IN THE SMART RING MARKET In a rapidly expanding wearable technology landscape, the Herz P1 Smart Ring distinguishes itself through a combination of precision engineering, user-focused design, and comprehensive functionality. While many smart rings offer basic tracking, the Herz P1 integrates an advanced set of features that appeal to both wellness enthusiasts and everyday users seeking reliable health insights. One of its defining attributes is the high-accuracy biometric sensor suite, which captures continuous heart rate, sleep stages, stress levels, and daily activity data. This level of detail is comparable to — and in some cases exceeds — what's found in larger wrist-worn devices, but without the added bulk. The ring's minimalist design also ensures it complements both casual and formal attire, making it practical for 24/7 wear. The Herz P1's companion mobile app enhances its usability by presenting clear, actionable information. Data visualizations allow users to easily interpret trends, while goal-setting tools help align daily habits with long-term health objectives. For those who value discretion, the device's low-profile form factor ensures advanced tracking without drawing attention, a benefit for professionals and individuals in social settings. Another key strength is its durability and comfort. Constructed from lightweight yet robust titanium alloy, the Herz P1 is resistant to scratches, moisture, and temperature fluctuations. The ergonomic inner band ensures a comfortable fit for long-term wear, even during intense workouts or overnight use. Battery life optimization means users can enjoy uninterrupted tracking for multiple days before needing to recharge. By merging fashion, comfort, and science-backed performance, the Herz P1 Smart Ring positions itself as a versatile choice in the wearables market — bridging the gap between traditional health trackers and next-generation, discreet monitoring solutions. SECTION 4 — INTEGRATION WITH OTHER DIGITAL HEALTH TOOLS The Herz P1 Smart Ring does not just operate in isolation; it seamlessly integrates with a variety of health and wellness platforms to offer a more holistic view of your wellness journey. It can sync with fitness apps like Strava or Google Fit, allowing users to consolidate their health data across multiple platforms for easier management and analysis. This integration enables users to set personalized wellness goals, track progress over time, and gain a deeper understanding of how their lifestyle affects their overall health. In addition, the Herz P1 is also designed to integrate with smart home devices such as sleep trackers, air purifiers, or temperature regulation systems, offering users a connected ecosystem for optimal wellness. Imagine your smart ring communicating with your home's thermostat to adjust the room temperature based on the sleep data it collects, or sending alerts about elevated stress levels to help prompt mindfulness practices — all integrated into one unified health experience. This interconnectedness makes the Herz P1 an essential part of any modern health monitoring routine, helping users make informed, data-driven decisions to support their long-term health goals. SECTION 5 — WHO BENEFITS MOST FROM USING THE HERZ P1 SMART RING The Herz P1 Smart Ring is designed to serve a diverse range of users, making it a versatile health monitoring solution for various lifestyles and wellness goals. Its discreet size and advanced capabilities appeal to those who value both functionality and aesthetics, while its ease of use ensures accessibility for individuals at different stages of their health journey. Health-conscious professionals are a prime audience, as the ring enables them to monitor key wellness metrics without disrupting their busy schedules. With its subtle design, it can be worn in boardrooms, during travel, or in client-facing roles without attracting attention, while still providing continuous tracking in the background. Athletes and fitness enthusiasts also stand to benefit from the Herz P1's precision tracking. By analyzing heart rate variability, recovery patterns, and sleep quality, they can fine-tune training programs and improve recovery strategies, ultimately supporting better performance outcomes. For individuals managing stress or seeking to improve sleep quality, the ring's continuous monitoring provides valuable feedback. Real-time stress detection empowers users to take preventative action, while detailed sleep insights help identify habits or factors that may be affecting rest. Older adults and those monitoring heart health can use the Herz P1 as a non-invasive, easy-to-wear tool to stay informed about their wellness status. Its intuitive app interface and long battery life make it a low-maintenance option for consistent use. Overall, the Herz P1's combination of accuracy, comfort, and all-day wearability ensures it can meet the needs of anyone seeking reliable, data-driven health insights without the inconvenience of larger, more obtrusive devices. SECTION 6 — THE GROWING MARKET FOR WEARABLE HEALTH TECHNOLOGY IN 2025 The wearable health technology market has seen consistent growth over the past decade, and 2025 is shaping up to be a pivotal year for innovation, adoption, and consumer expectations. Advancements in sensor technology, data analytics, and miniaturization have opened the door for devices like the Herz P1 Smart Ring to provide comprehensive monitoring in a discreet, stylish form. A major factor driving demand is the increased consumer focus on preventative health. Rather than waiting for medical issues to arise, individuals are seeking tools that can help them monitor their wellness daily, catch early warning signs, and make informed lifestyle adjustments. Wearables offer a convenient way to collect and review this data without requiring invasive procedures or frequent clinic visits. The rise of remote work and hybrid lifestyles has also played a role. With more time spent at home, users are taking a greater interest in self-tracking and optimizing health habits. Devices that deliver actionable insights — such as sleep cycle reports, heart rate trends, and stress level analysis — are in high demand. Additionally, the integration of AI and cloud-based analytics is transforming the wearable experience. Smart rings like the Herz P1 can sync with secure apps to provide personalized recommendations based on long-term data patterns, allowing for a level of customization that was not possible just a few years ago. Finally, the fashion-forward approach to wearable design is attracting a broader demographic. The Herz P1's minimalistic, premium look means it appeals not only to tech enthusiasts but also to style-conscious users who previously avoided bulkier health trackers. With these trends converging, the wearable tech sector is set for rapid expansion, and smart rings are emerging as one of the most promising categories within it. Discover how the Herz P1 Smart Ring supports health and wellness monitoring. SECTION 7 — CONTACT INFORMATION Company: WuzuTech Herz P1Email: support@ Support: (866) 479-1629 Address:WuzuTech LLC839 E Market StSte 106 #165Akron, OH 44305United States Disclaimer: The statements in this release are for informational purposes only and are not intended to diagnose, treat, cure, or prevent any disease or health condition. The information provided about the Herz P1 Smart Ring is based on publicly available sources, manufacturer claims, and product descriptions at the time of publication. Individual results from using the product may vary. This release does not constitute medical advice, and readers should consult a qualified healthcare professional before starting or changing any health-related regimen, including the use of wearable health devices. The Herz P1 Smart Ring is designed as a consumer wellness product and should not replace professional medical equipment or services. The publisher of this release has no liability for any direct, indirect, or consequential damages arising from the use or misuse of the product. All product names, logos, and brands are the property of their respective owners. CONTACT: Email: support@ Phone Support: (866) 479-1629

New York declares total war on prolific rat population
New York declares total war on prolific rat population

Yahoo

time22 minutes ago

  • Yahoo

New York declares total war on prolific rat population

New York is waging a war on multiple fronts to combat the near ubiquitous rats that plague city streets and the subways, leaving some residents afraid to let their children walk on sidewalks. Faced with an overwhelming and ever-growing problem, officials have moved beyond gassing burrows to suffocate rodents and are now using high-tech mapping tools to try and sterilize the population. Alongside targeted interventions, officials are mounting an effort to educate the public about the need to avoid leaving behind food waste that feeds and sustains the rat population. Caroline Bragdon, director of neighborhood interventions for Pest Control Services within New York City's Department of Health, told AFP that the lack of food "stresses" rats and other vermin. "Perhaps this forces them to go further in search of food, but perhaps they simply have fewer offspring," she said. "That's usually what we're seeing. Fewer rats over time. Less breeding leads to less rat activity," Bragdon added. The city is testing out an arsenal of different tools in the Harlem neighborhood, aiming to find new products and methods to tackle the rats. For large, densely populated cities like New York -- with its 8.5 million inhabitants -- food sources for the rodents are bountiful, whether it's on sidewalks, in overflowing trash bins, or in parks. "Lately, I haven't felt that I have to run in between the mounds of trash to run away from rats because they have those new (sealed trash) containers," said Harlem resident Karen Del Aguila, 50. Rats, which survive on practically the same diet as humans, can flourish even on items discarded as trash -- like soda cans thrown into recycling bins, or crumbs given to pigeons, warned Bragdon. A rat needs one ounce (28 grams) of food per day to sustain itself, and it can have up to 12 offspring per litter. During its short life of less than a year, it can have between five and seven litters. The best way to counter the scourge of rats is to "remove their food source... So make it harder for them, then they're going to have to travel further to try and find something," said Alexa Albert, a supervisor for the city's pest control service. - 'It can be done' - She swiped her screen to show the street-level data logged on a rat tracker app used by those involved in the crusade against rodent infestation. The city health department's 70 inspectors use the mobile app to detect, report and monitor rodent activity -- as well as plot abatement tactics. Inspectors go door to door asking businesses and residents to clean buildings, stores, and sidewalks. Authorities also now offer training on how to combat rats, taken by thousands of residents and building managers. In October 2022, New York City vaunted a "trash revolution," aimed at installing sealed containers to allow the removal of black bags of organic waste from sidewalks after rats surged during the coronavirus pandemic. Pre-pandemic, their population had been cut by as much as 90 percent in some areas. "So we know it can be done," said Bragdon, who added that she hoped 2025 would be a "turnaround year." Local resident Jessica Sanchez said she had observed much fewer rats in her neighborhood. "Not a long time ago, when you went to put out the trash, five of them came out," she said. "I was even afraid to put my son on the floor." The rat warriors are seeking to learn the rodents' dietary habits throughout the year by using samples of different food types to identify what bait they are most likely to take. In 2024, complaints about rat activity dropped 25 percent compared to the year before, according to official data. But so far, only Manhattan's Chinatown has managed to bring the rat population under control. af-gw/sla

Moderna Is Cutting 10,000 Jobs as Its Business Erodes. How Should You Play MRNA Stock Here?
Moderna Is Cutting 10,000 Jobs as Its Business Erodes. How Should You Play MRNA Stock Here?

Yahoo

time25 minutes ago

  • Yahoo

Moderna Is Cutting 10,000 Jobs as Its Business Erodes. How Should You Play MRNA Stock Here?

Moderna (MRNA) skyrocketed to fame during the pandemic, delivering one of the first mRNA-based Covid-19 vaccines and quickly becoming a Wall Street darling. Its vaccine shot brought in billions, positioning the biotech firm as a symbol of innovation and speed in a global crisis. But the post-Covid world hasn't been as kind. With vaccination rates falling and Spikevax sales drying up, revenues have tumbled. The gold rush moment is clearly over. Now, in a bid to stay lean, Moderna is cutting roughly 10% of its workforce as part of a broader plan to reduce annual operating expenses by $1.5 billion through 2027. The company tried to dodge layoffs by tightening R&D budgets, dialing down manufacturing, and renegotiating supplier deals. But with the market shifting and respiratory vaccine sales stalling, CEO Stéphane Bancel says it's time to realign the business with a leaner game plan. More News from Barchart Supermicro's Earnings Selloff Explained: Should You Buy SMCI Stock Now? Amazon's $36M Bet on Quantum Computing: What Investors Need to Know AMD Stock Slips After Q2 Earnings, But Here's Why It's a Buying Opportunity Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! The company is betting big on a pipeline loaded with promise — next-gen mRNA shots in oncology, rare diseases, and latent viruses. But with MRNA stock down more than 90% from its pandemic highs and policy headwinds brewing, is this a comeback play or a value trap? How should investors approach the biotech stock now? About Moderna Stock Based in Cambridge, Massachusetts and founded in 2010, Moderna began as a moonshot on mRNA tech, chasing cures for infectious diseases, rare disorders, cancer, and more. Backed by major players like AstraZeneca (AZN) and the Gates Foundation, it built a powerful platform with world-changing potential. Its market capitalization currently stands at $10.4 billion. When the pandemic hit, Moderna went from a clinical-stage underdog to a global hero with a Covid-19 vaccine that changed everything. But as the world moved on, demand faded, and so did the company's momentum. After peaking just shy of $500 in 2021, MRNA stock has crashed 94% from that level. In 2025 alone, shares are down 37%, including a 12% dip in just the past month. A lukewarm second-quarter earnings report last week triggered a 6.6% dip in just one session. In terms of valuation, MRNA stock is trading at 3.3 times sales, which is lower than its own five-year average multiple. Moderna's Mixed Q2 Earnings Report On Aug. 1, Moderna dropped its Q2 earnings report, showing signs of tighter control amid a post-Covid reset. The company posted a loss of $2.13 per share, still in the red, but better than both Wall Street's projections and last year's results. Revenue came in at $142 million, down 41% year-over-year (YOY) but still ahead of estimates. The decline was due to shrinking demand for its Covid-19 vaccine, Spikevax, which made up nearly all of the $114 million in product sales. The real story here isn't just about numbers but about a pivot. With the pandemic in the rearview, Spikevax is settling into its new role as a seasonal product, and mResvia — the company's newly launched RSV vaccine — barely moved the needle this quarter. Add to that a sharp 51% drop in collaboration and licensing revenue, and it is clear the biotech is feeling the squeeze. So, Moderna is tightening its belt, and fast. Operating costs are being hacked down as part of a major restructuring. SG&A expenses fell 14%, and R&D was slashed 43% to $700 million, largely due to scaled-back respiratory programs and slower clinical activity. But perhaps the most visible shift is in the workforce. As part of the company's cost-streamlining drive, it is trimming nearly 10% of its global staff. It's a tough call, but a necessary one to keep the long-term mission on track. Looking forward, Moderna revised its full-year revenue guidance to between $1.5 billion and $2.2 billion, down $300 million from its earlier high-end forecast. The reason is that a delivery delay of U.K. vaccine orders has now pushed into early 2026. Most of the 2025 revenue is expected to roll in during the second half, with Q3 pulling in about 40% to 50% of that haul. Meanwhile, R&D guidance has also been trimmed to $3.6 billion and $3.8 billion, aligning with workforce reductions and lower clinical spend. Despite the turbulence, the company is set to close 2025 with approximately $6 billion in cash and investments — a solid cushion for navigating whatever comes next. Analysts tracking the biotech company anticipate Moderna's losses to deepen by 11% YOY to around -$9.82 per share in fiscal 2025, then narrow by 27% annually to -$7.21 per share in fiscal 2026. What Do Analysts Expect for Moderna Stock? After Moderna's Q2 earnings release, Wall Street's confidence took a softer tone, reflected clearly in the updated price targets. Bank of America nudged its target down to $24 from $25, holding firm on its 'Underperform' rating. Analyst Tim Anderson is not sold on Moderna's long-term growth story, pointing out that the company's near- and mid-term outlook still leans heavily on Covid vaccine sales, which are notoriously hard to predict in this post-pandemic world. Bank of America has been skeptical for a while. The firm reinstated coverage back in December with that same 'Underperform' call, flagging doubts about the company's other programs like RSV and CMV. Despite Moderna's push to diversify, the brokerage firm is not yet convinced there's enough there to support sustainable growth. Barclays also reined things in, trimming its price target from $40 to $31 while maintaining an 'Equal Weight' rating. Analyst Gena Wang said the downward shift stems largely from Moderna pushing some U.K. vaccine revenue into early 2026. Still, Wang believes further cost-cutting should help Moderna stay on track with its goal of breaking even by 2028. Moderna's reinvention pitch is loud, but the Street is staying cautious. Among the 26 analysts covering MRNA stock, the consensus rating is a 'Hold.' That's based on three analysts recommending a 'Strong Buy,' 19 advising a 'Hold,' one giving a 'Moderate Sell,' and the remaining three suggesting a 'Strong Sell.' The mean price target of $41.90 for MRNA stock suggests more than 57% upside potential from current levels. The Street-high target of $198 implies that the stock could rally as much as 644%. On the date of publication, Sristi Suman Jayaswal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store